Enrollment open in phase III study of fostamatinib in warm antibody autoimmune hemolytic anemia May 17, 2019 No Comments
Sevuparin fails to show meaningful benefit in phase II trial to manage VOC in sickle cell disease May 14, 2019 No Comments
Pooled safety analyses of global roxadustat phase III program confirm CV safety May 10, 2019 No Comments
Conditional marketing authorization granted in E.U. for Ondexxya to reverse factor Xa inhibitors April 29, 2019 No Comments
Researchers create animal model of orthopedic injury-induced hypercoagulability April 24, 2019 No Comments
RSS